Article Dans Une Revue ACS Biomaterials Science and Engineering Année : 2025

Nano-Enabled Effective Tuberculosis Treatments: A Concise Overview

Résumé

Tuberculosis (TB) is a severe respiratory infectious disease caused by Mycobacterium tuberculosis (M.tb), which puts enormous pressure on public health and economic systems worldwide. Therefore, accurate diagnosis and timely intervention of TB are critical for interrupting disease transmission and reducing mortality among TB patients. However, the low bioavailability, inadequate targeting, and significant adverse side effects of conventional antibiotics and the emergence of the multidrug-resistant M.tb strain result in limited TB treatment efficacy or even the development of multidrug-resistant TB. The development of nanomaterials provides new perspectives to improve the drawbacks of antibiotics for improved TB treatment, while enabling the diagnosis of TB. Herein, we review the conventional and nanotechnology-based diagnosis and intervention strategy of TB and the currently developed novel methods to solve the TB dilemma.

Fichier non déposé

Dates et versions

hal-05298660 , version 1 (06-10-2025)

Identifiants

Citer

Jingjing Li, Huxiao Sun, Dzmitry Shcharbin, Serge Mignani, Jean-Pierre Majoral, et al.. Nano-Enabled Effective Tuberculosis Treatments: A Concise Overview. ACS Biomaterials Science and Engineering, 2025, 11 (5), pp.2492-2501. ⟨10.1021/acsbiomaterials.4c02109⟩. ⟨hal-05298660⟩
36 Consultations
0 Téléchargements

Altmetric

Partager

  • More